These studies were focused on the association between different genera and species of colonic, commensal bacteria and the responsiveness of patients, mostly with metastatic melanoma or urothelial carcinoma, to PD-1/PD-L1-targeted immunotherapy (82–84). This evidence concerns the gene PDCD1 and urothelial carcinoma.